Sabin, Lora L. http://orcid.org/0000-0002-2782-542X
Simmons, Elizabeth
Halim, Nafisa
Hamer, Davidson H.
Gifford, Allen L.
West, Rebecca L.
Larson, Anna
Bonawitz, Rachael
Aroda, Philip
Banigbe, Bolanle
Holderman, Alayna J.
Murray, Lisa
DeSilva, Mary B.
Gasuza, Julia
Mukasa, Barbara
Messersmith, Lisa J.
Funding for this research was provided by:
National Institutes of Health (1R34MN103075)
Article History
Accepted: 10 May 2022
First Online: 15 June 2022
Declarations
:
: Anna Larson is currently employed by Merck and has received past funding from them for vaccine policy work unrelated to this study. All other authors have no relevant financial or non-financial interests to disclose. All authors declare that they have no conflicts of interest.
: All procedures performed in studies involving human participants were in accordance with ethical standards of the institutional review board at Boston University Medical Center, the research ethics committee of the School of Medicine (SOMREC) at Makerere University’s College of Health Sciences in Kampala, Uganda, the Uganda National Council of Science and Technology (UNCST), and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all participants in this study.
: Informed consent forms included the language: “The information may be published, but your name will not be used in any publications.”
: A subset of study findings was presented to government officials and non-government personnel in Uganda in Feb-March 2018 and at the 12th International Conference on HIV Treatment and Prevention (June 2017). However, all findings presented previously were preliminary and did not include the full set of analyses presented here.